• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症生存分析的混合模型:在具有协变量的基于人群的数据中的应用。

Mixture models for cancer survival analysis: application to population-based data with covariates.

作者信息

De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A

机构信息

Istituto Superiore di Sanità, Laboratory of Epidemiology and Biostatistics, Roma, Italy.

出版信息

Stat Med. 1999 Feb 28;18(4):441-54. doi: 10.1002/(sici)1097-0258(19990228)18:4<441::aid-sim23>3.0.co;2-m.

DOI:10.1002/(sici)1097-0258(19990228)18:4<441::aid-sim23>3.0.co;2-m
PMID:10070685
Abstract

The interest in estimating the probability of cure has been increasing in cancer survival analysis as the curability of many cancer diseases is becoming a reality. Mixture survival models provide a way of modelling time to death when cure is possible, simultaneously estimating death hazard of fatal cases and the proportion of cured case. In this paper we propose an application of a parametric mixture model to relative survival rates of colon cancer patients from the Finnish population-based cancer registry, and including major survival determinants as explicative covariates. Disentangling survival into two different components greatly facilitates the analysis and the interpretation of the role of prognostic factors on survival patterns. For example, age plays a different role in determining, from one side, the probability of cure, and, from the other side, the life expectancy of fatal cases. The results support the hypothesis that observed survival trends are really due to a real prognostic gain for more recently diagnosed patients.

摘要

随着许多癌症疾病的可治愈性成为现实,在癌症生存分析中,对估计治愈概率的兴趣日益增加。混合生存模型提供了一种在可能治愈的情况下对死亡时间进行建模的方法,同时估计致命病例的死亡风险和治愈病例的比例。在本文中,我们提出将参数混合模型应用于来自芬兰基于人群的癌症登记处的结肠癌患者的相对生存率,并将主要生存决定因素作为解释性协变量纳入。将生存分解为两个不同的组成部分极大地促进了对预后因素在生存模式中的作用的分析和解释。例如,年龄在确定治愈概率和致命病例的预期寿命方面发挥着不同的作用。结果支持这样的假设,即观察到的生存趋势确实是由于最近诊断的患者真正的预后改善。

相似文献

1
Mixture models for cancer survival analysis: application to population-based data with covariates.用于癌症生存分析的混合模型:在具有协变量的基于人群的数据中的应用。
Stat Med. 1999 Feb 28;18(4):441-54. doi: 10.1002/(sici)1097-0258(19990228)18:4<441::aid-sim23>3.0.co;2-m.
2
The cure for colon cancer: results from the EUROCARE study.结肠癌的治疗:EUROCARE研究结果
Int J Cancer. 1998 Jul 29;77(3):322-9. doi: 10.1002/(sici)1097-0215(19980729)77:3<322::aid-ijc2>3.0.co;2-q.
3
Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.北欧国家 1964-2003 年间诊断为癌症的患者的生存趋势,随访至 2006 年底。材料和方法。
Acta Oncol. 2010 Jun;49(5):545-60. doi: 10.3109/02841861003739322.
4
Estimating and modeling the cure fraction in population-based cancer survival analysis.基于人群的癌症生存分析中治愈分数的估计与建模。
Biostatistics. 2007 Jul;8(3):576-94. doi: 10.1093/biostatistics/kxl030. Epub 2006 Oct 4.
5
Estimating the proportion cured of cancer: some practical advice for users.估算癌症治愈比例:用户实用建议。
Cancer Epidemiol. 2013 Dec;37(6):836-42. doi: 10.1016/j.canep.2013.08.014. Epub 2013 Sep 14.
6
Testing equality of relative survival patterns based on aggregated data.
Biometrics. 1987 Jun;43(2):313-25.
7
Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.不同癌症预期寿命损失估算模型假设的图示。
BMC Med Res Methodol. 2019 Jul 9;19(1):145. doi: 10.1186/s12874-019-0785-x.
8
Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?结肠癌相对生存趋势中的风险回归模型和治愈率模型:它们讲述的是同一个故事吗?
Eur J Epidemiol. 2008;23(4):251-9. doi: 10.1007/s10654-008-9226-6. Epub 2008 Feb 9.
9
Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.基于灵活参数生存模型的基于人群的癌症研究中的估计和建模治愈。
BMC Med Res Methodol. 2011 Jun 22;11:96. doi: 10.1186/1471-2288-11-96.
10
Mixed estimation of old-age mortality.老年死亡率的混合估计。
Math Popul Stud. 1997;6(4):319-30, 335. doi: 10.1080/08898489709525440.

引用本文的文献

1
Incorporating latent survival trajectories and covariate heterogeneity in time-to-event data analysis: a joint mixture model approach.在生存时间数据分析中纳入潜在生存轨迹和协变量异质性:一种联合混合模型方法。
BMC Med Res Methodol. 2025 May 14;25(1):132. doi: 10.1186/s12874-025-02580-8.
2
Estimating cure proportion in cancer clinical trials using flexible parametric cure models.使用灵活的参数治愈模型估计癌症临床试验中的治愈比例。
BJC Rep. 2024 Aug 28;2(1):61. doi: 10.1038/s44276-024-00092-4.
3
Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials.
评估 III/IV 期黑色素瘤切除患者的长期生存率:来自 CheckMate 238 和欧洲癌症研究与治疗组织 18071 试验的分析
J Clin Oncol. 2025 Mar 10;43(8):929-937. doi: 10.1200/JCO.24.00237. Epub 2024 Oct 8.
4
General Population Mortality Adjustment in Survival Extrapolation of Cancer Trials: Exploring Plausibility and Implications for Cost-Effectiveness Analyses in HER2-Positive Breast Cancer in Sweden.癌症试验生存外推中的一般人群死亡率调整:探索在瑞典 HER2 阳性乳腺癌中的成本效益分析中的合理性和影响。
Med Decis Making. 2024 Oct;44(7):843-853. doi: 10.1177/0272989X241275969. Epub 2024 Sep 12.
5
Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in China.鼻咽癌治愈证据:一项基于中国患者的多中心研究结果
Lancet Reg Health West Pac. 2024 Jul 19;49:101147. doi: 10.1016/j.lanwpc.2024.101147. eCollection 2024 Aug.
6
: An End-to-End Pipeline for Implementing Mixture Cure Models With an Application to Liposarcoma Data.: 一个用于实现混合治愈模型的端到端管道,应用于脂肪肉瘤数据。
JCO Clin Cancer Inform. 2024 Aug;8:e2300234. doi: 10.1200/CCI.23.00234.
7
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know.用于卫生技术评估的混合与非混合治愈模型:你需要了解的内容。
Pharmacoeconomics. 2024 Oct;42(10):1073-1090. doi: 10.1007/s40273-024-01406-7. Epub 2024 Jul 5.
8
Potential for Cure by Stage across the Cancer Spectrum in the United States.美国不同癌症阶段的治愈潜力。
Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):206-214. doi: 10.1158/1055-9965.EPI-23-1018.
9
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.癌症治愈的总体患病率及指标:意大利基于人群的癌症登记处的强化方法与验证
Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023.
10
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group.癌症治愈及其对生存护理的影响:来自意大利抗癌联盟(ACC)生存护理工作组的立场文件。
Cancer Manag Res. 2022 Oct 31;14:3105-3118. doi: 10.2147/CMAR.S380390. eCollection 2022.